Acute hypothermia induced by valproic acid.

Proc (Bayl Univ Med Cent)Mar 27, 2026 (epub)
Case ReportNeurologyEmergency MedicineOpen access

Harshith Dasara, Bradley Conn, Sadat Shamim

✦ AI-curated · Sources linked

Case in brief

A patient presenting with seizures developed repeated episodes of acute hypothermia shortly after receiving valproic acid. The clinical workup and timing of the episodes supported an association with the medication. The report describes treatment and discusses possible mechanisms, while noting that the mechanism is not fully understood.

What made this case unusual

The notable feature was recurrent hypothermia temporally associated with valproic acid administration, an underappreciated adverse effect that may prompt evaluation for other causes such as sepsis.

Diagnostic / clinical pearl

Consider valproic acid as a possible contributor when hypothermia occurs soon after its administration, while assessing the patient for other causes.

Why it matters

Recognizing this potential adverse effect may help avoid repeated sepsis workups in hospitalized patients and complications in outpatient settings.

Source

Published in Proc (Bayl Univ Med Cent). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.